Viva Biotech (1873 HK)

Analysis

Health Care • China

Viva Biotech Holdings provides one-stop services ranging from early-stage structure-based drug R&D to commercial manufacturing for global biopharmaceutical innovators. The company offers drug discovery services (CRO) and contract development and manufacturing services (CDMO) for small molecules and biologics. It was established in 2008 and is headquartered in Shanghai, China.

Refresh

Exchange Announcement • 22 Sep 2026 16:37

Interim Report 2026

Exchange Announcement • 26 Aug 2026 18:20

Interim Results Announcement For The Six Months Ended June 30, 2026

Exchange Announcement • 14 Aug 2026 16:30

Date Of Board Meeting

Exchange Announcement • 14 Jul 2026 17:04

Next Day Disclosure Return

Exchange Announcement • 26 Jun 2026 19:21

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00